
This has led the market stakeholders to focus on collaborations and partnerships, particularly overseas, to meet the rising demand while expanding their global footprint. The growth of the clinical oncology next-generation sequencing market is expected to remain influenced by growing government funding for the life science projects, coupled with declining prices of the sequencing processes. Aforementioned insights have been sourced from the report – "Clinical Oncology Next-Generation Sequencing Market: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029" – incorporated recently into Market Research Hub's (MRH) database. North America will remain the most lucrative market for the clinical oncology next-generation sequencing market. However, gains are expected to grow at a relatively faster pace in the developing markets, such as South Korea, India, and China, in the near future.